ALK and adenocarcinoma: Some trials suggest adenocarcinoma in itself is a risk factor for VTE,34 while others did not demonstrate such an association.35,36 Therefore, this difference in histology may have led to overestimation of the VTE risk associated with ALK mutations in lung cancer.